Cargando…
Immunisation Using Novel DNA Vaccine Encoding Virus Membrane Fusion Complex and Chemokine Genes Shows High Protection from HSV-2
Herpes simplex virus 1 and 2 infections cause high unmet disease burdens worldwide. Mainly HSV-2 causes persistent sexually transmitted disease, fatal neonatal disease and increased transmission of HIV/AIDS. Thus, there is an urgent requirement to develop effective vaccines. We developed nucleic aci...
Autores principales: | Gompels, Ursula A., Bravo, Fernando J., Briggs, Sean, Ameri, Shima, Cardin, Rhonda D., Bernstein, David I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698128/ https://www.ncbi.nlm.nih.gov/pubmed/36366414 http://dx.doi.org/10.3390/v14112317 |
Ejemplares similares
-
The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model
por: Bernstein, David I., et al.
Publicado: (2020) -
Successful application of prime and pull strategy for a therapeutic HSV vaccine
por: Bernstein, David I., et al.
Publicado: (2019) -
Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials
por: Bernstein, David I., et al.
Publicado: (2019) -
CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway
por: Catusse, Julie, et al.
Publicado: (2009) -
Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
por: Casto, Amanda M., et al.
Publicado: (2020)